Founded in 1992 and headquartered in Chennai, Orchid Pharma is a vertically integrated pharmaceutical company with a proven legacy in research, manufacturing, and global partnerships. We are pioneers in the development and production of cephalosporin APIs and finished dosage forms, serving over 50 countries worldwide. Our therapeutic strength spans anti-infectives, CNS, CVS, anti-inflammatory, and nutraceutical segments, supported by USFDA, EU, and other globally approved manufacturing facilities. We are proud to be one of the few Indian companies to discover and license a New Chemical Entity (NCE), Enmetazobactam now approved in the US, EU, and India. With a diverse and niche product basket, a strong R&D foundation, and a renewed growth trajectory under the Dhanuka Group (since 2020), Orchid Pharma is committed to advancing evidence-based, responsible, and accessible healthcare for a global population.
| Website | https://www.orchidpharma.com/ |
| Revenue | $98 million |
| Employees | 17 (1 on RocketReach) |
| Industry | Hospitals and Health Care |
| Competitors | Mylan Belgium, Teva Pharmaceuticals, SUN PHARMA, Dr. Reddy's Laboratories, Cipla, Zydus Cadila Healthcare Limited, Sandoz, Aurobindo Pharma LTD, Lupin Limited, Hetero +47 more (view full list) |
Looking for a particular Orchid Pharma employee's phone or email?
The Orchid Pharma annual revenue was $98 million in 2026.
Aasim Khan is the Sales Executive of Orchid Pharma.
1 people are employed at Orchid Pharma.